BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 34091126)

  • 1. Loss of ZNF215 imprinting is associated with poor five-year survival in patients with cytogenetically abnormal-acute myeloid leukemia.
    Yang MY; Lin PM; Yang CH; Hu ML; Chen IY; Lin SF; Hsu CM
    Blood Cells Mol Dis; 2021 Sep; 90():102577. PubMed ID: 34091126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered expression of imprinted genes in patients with cytogenetically normal‑acute myeloid leukemia: Implications for leukemogenesis and survival outcomes.
    Yang MY; Hsu CM; Lin PM; Yang CH; Hu ML; Chen IY; Lin SF
    Mol Clin Oncol; 2023 Dec; 19(6):94. PubMed ID: 37920417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered Expression of Imprinted Genes in Squamous Cell Carcinoma of the Head and Neck.
    Hsu CM; Lin PM; Lin HC; Lai CC; Yang CH; Lin SF; Yang MY
    Anticancer Res; 2016 May; 36(5):2251-8. PubMed ID: 27127130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and prognostic impact of lncRNAs in acute myeloid leukemia.
    Garzon R; Volinia S; Papaioannou D; Nicolet D; Kohlschmidt J; Yan PS; Mrózek K; Bucci D; Carroll AJ; Baer MR; Wetzler M; Carter TH; Powell BL; Kolitz JE; Moore JO; Eisfeld AK; Blachly JS; Blum W; Caligiuri MA; Stone RM; Marcucci G; Croce CM; Byrd JC; Bloomfield CD
    Proc Natl Acad Sci U S A; 2014 Dec; 111(52):18679-84. PubMed ID: 25512507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA sequence polymorphisms in a panel of eight candidate bovine imprinted genes and their association with performance traits in Irish Holstein-Friesian cattle.
    Magee DA; Sikora KM; Berkowicz EW; Berry DP; Howard DJ; Mullen MP; Evans RD; Spillane C; MacHugh DE
    BMC Genet; 2010 Oct; 11():93. PubMed ID: 20942903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BAALC overexpression retains its negative prognostic role across all cytogenetic risk groups in acute myeloid leukemia patients.
    Damiani D; Tiribelli M; Franzoni A; Michelutti A; Fabbro D; Cavallin M; Toffoletti E; Simeone E; Fanin R; Damante G
    Am J Hematol; 2013 Oct; 88(10):848-52. PubMed ID: 23760853
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Zhang TJ; Zhou JD; Zhang W; Lin J; Ma JC; Wen XM; Yuan Q; Li XX; Xu ZJ; Qian J
    Clin Epigenetics; 2018; 10():47. PubMed ID: 29643943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TET2 expression is a potential prognostic and predictive biomarker in cytogenetically normal acute myeloid leukemia.
    Zhang TJ; Zhou JD; Yang DQ; Wang YX; Wen XM; Guo H; Yang L; Lian XY; Lin J; Qian J
    J Cell Physiol; 2018 Aug; 233(8):5838-5846. PubMed ID: 29219176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An 86-probe-set gene-expression signature predicts survival in cytogenetically normal acute myeloid leukemia.
    Metzeler KH; Hummel M; Bloomfield CD; Spiekermann K; Braess J; Sauerland MC; Heinecke A; Radmacher M; Marcucci G; Whitman SP; Maharry K; Paschka P; Larson RA; Berdel WE; Büchner T; Wörmann B; Mansmann U; Hiddemann W; Bohlander SK; Buske C; ;
    Blood; 2008 Nov; 112(10):4193-201. PubMed ID: 18716133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of the IGF-2/H19 locus during normal and malignant hematopoiesis is independent of the imprinting pattern.
    Tessema M; Länger F; Bock O; Seltsam A; Metzig K; Hasemeier B; Kreipe H; Lehmann U
    Int J Oncol; 2005 Feb; 26(2):499-507. PubMed ID: 15645136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic aberrations in acute myeloid leukemia: Early key events during leukemogenesis.
    Eriksson A; Lennartsson A; Lehmann S
    Exp Hematol; 2015 Aug; 43(8):609-24. PubMed ID: 26118500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High EVI1 expression predicts outcome in younger adult patients with acute myeloid leukemia and is associated with distinct cytogenetic abnormalities.
    Gröschel S; Lugthart S; Schlenk RF; Valk PJ; Eiwen K; Goudswaard C; van Putten WJ; Kayser S; Verdonck LF; Lübbert M; Ossenkoppele GJ; Germing U; Schmidt-Wolf I; Schlegelberger B; Krauter J; Ganser A; Döhner H; Löwenberg B; Döhner K; Delwel R
    J Clin Oncol; 2010 Apr; 28(12):2101-7. PubMed ID: 20308656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD97 expression is associated with poor overall survival in acute myeloid leukemia.
    Vaikari VP; Yang J; Wu S; Alachkar H
    Exp Hematol; 2019 Jul; 75():64-73.e4. PubMed ID: 31260716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of novel molecular markers for prognosis estimation of acute myeloid leukemia: over-expression of PDCD7, FIS1 and Ang2 may indicate poor prognosis in pretreatment patients with acute myeloid leukemia.
    Tian Y; Huang Z; Wang Z; Yin C; Zhou L; Zhang L; Huang K; Zhou H; Jiang X; Li J; Liao L; Yang M; Meng F
    PLoS One; 2014; 9(1):e84150. PubMed ID: 24416201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-utero stress and mode of conception: impact on regulation of imprinted genes, fetal development and future health.
    Argyraki M; Damdimopoulou P; Chatzimeletiou K; Grimbizis GF; Tarlatzis BC; Syrrou M; Lambropoulos A
    Hum Reprod Update; 2019 Nov; 25(6):777-801. PubMed ID: 31633761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of CEBPA mutations and promoter hypermethylation in pediatric acute myeloid leukemia.
    Hollink IH; van den Heuvel-Eibrink MM; Arentsen-Peters ST; Zimmermann M; Peeters JK; Valk PJ; Balgobind BV; Sonneveld E; Kaspers GJ; de Bont ES; Trka J; Baruchel A; Creutzig U; Pieters R; Reinhardt D; Zwaan CM
    Haematologica; 2011 Mar; 96(3):384-92. PubMed ID: 21134981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survivin' Acute Myeloid Leukaemia-A Personalised Target for inv(16) Patients.
    Greiner J; Brown E; Bullinger L; Hills RK; Morris V; Döhner H; Mills KI; Guinn BA
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of imprinting of human insulin-like growth factor II gene, IGF2, in acute myeloid leukemia.
    Wu HK; Weksberg R; Minden MD; Squire JA
    Biochem Biophys Res Commun; 1997 Feb; 231(2):466-72. PubMed ID: 9070302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The combined expression of HOXA4 and MEIS1 is an independent prognostic factor in patients with AML.
    Zangenberg M; Grubach L; Aggerholm A; Silkjaer T; Juhl-Christensen C; Nyvold CG; Kjeldsen E; Ommen HB; Hokland P
    Eur J Haematol; 2009 Nov; 83(5):439-48. PubMed ID: 19563517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylation-independent CHFR expression is a potential biomarker affecting prognosis in acute myeloid leukemia.
    Zhou JD; Zhang TJ; Li XX; Ma JC; Guo H; Wen XM; Yao DM; Zhang W; Lin J; Qian J
    J Cell Physiol; 2018 Jun; 233(6):4707-4714. PubMed ID: 29115660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.